Log In
Print
BCIQ
Print
Print this Print this
 

BB-001

  Manage Alerts
Collapse Summary General Information
Company Bullet Biotechnology Inc.
DescriptionPersonalized active immunotherapy consisting of the idiotype protein on B cell lymphoma cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today